A 58-year-old woman with a 1.5 cm nodular basal cell carcinoma on the nose is deemed a poor candidate for surgical excision due to comorbidities and patient preference. Which is the preferred systemic drug for advanced or inoperable basal cell carcinoma?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.